128 related articles for article (PubMed ID: 17563278)
1. Injection drug users' strategies to manage perceptions of personal risk: how do IDUs see HIV as having affected them?
Smith KC; Lillie Tle L; Latkin C
AIDS Educ Prev; 2007 Jun; 19(3):245-57. PubMed ID: 17563278
[TBL] [Abstract][Full Text] [Related]
2. The dynamics of injection drug users' personal networks and HIV risk behaviors.
Costenbader EC; Astone NM; Latkin CA
Addiction; 2006 Jul; 101(7):1003-13. PubMed ID: 16771892
[TBL] [Abstract][Full Text] [Related]
3. The anatomy of risk: a quantitative investigation into injection drug users' taxonomy of risk attitudes and perceptions.
Marsch LA; Bickel WK; Badger GJ; Quesnel KJ
Exp Clin Psychopharmacol; 2007 Apr; 15(2):195-203. PubMed ID: 17469943
[TBL] [Abstract][Full Text] [Related]
4. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
5. HIV risk behavior among injection drug users in Tehran, Iran.
Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
[TBL] [Abstract][Full Text] [Related]
6. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
7. [Sex and drug: correlation of risk perception and behavioral patterns among intravenous drug users].
Márványkövi F; Melles K; Rácz J
Psychiatr Hung; 2006; 21(3):241-55. PubMed ID: 17090836
[TBL] [Abstract][Full Text] [Related]
8. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
[TBL] [Abstract][Full Text] [Related]
9. Social context of needle selling in Baltimore, Maryland.
Latkin CA; Davey MA; Hua W
Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and perception of risk for HIV and condom use among male injecting drug users in Cebu City, Philippines.
Amadora-Nolasco F; Alburo RE; Aguilar EJ; Trevathan WR
Drug Alcohol Rev; 2002 Jun; 21(2):137-43. PubMed ID: 12188992
[TBL] [Abstract][Full Text] [Related]
11. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
[TBL] [Abstract][Full Text] [Related]
12. HIV prevention for injecting drug users: the first 25 years and counting.
Des Jarlais DC; Semaan S
Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
[TBL] [Abstract][Full Text] [Related]
13. Urging others to be healthy: "intravention" by injection drug users as a community prevention goal.
Friedman SR; Maslow C; Bolyard M; Sandoval M; Mateu-Gelabert P; Neaigus A
AIDS Educ Prev; 2004 Jun; 16(3):250-63. PubMed ID: 15237054
[TBL] [Abstract][Full Text] [Related]
14. Demographic characteristics, treatment history, drug risk behaviors, and condom use attitudes for U.S. and Russian injection drug users: the need for targeted sexual risk behavior interventions.
Ksobiech K; Somlai AM; Kelly JA; Gore-Felton C; Benotsch E; McAuliffe T; Hackl K; Ostrovski D; Kozlov AP
AIDS Behav; 2005 Mar; 9(1):111-20. PubMed ID: 15812618
[TBL] [Abstract][Full Text] [Related]
15. Severe anxiety symptomatology and HIV risk behavior among Hispanic injection drug users in Puerto Rico.
Reyes JC; Robles RR; Colón HM; Marrero CA; Matos TD; Calderón JM; Shepard EW
AIDS Behav; 2007 Jan; 11(1):145-50. PubMed ID: 17122902
[TBL] [Abstract][Full Text] [Related]
16. Drug users talk about HIV testing: motivating and deterring factors.
Downing M; Knight K; Reiss TH; Vernon K; Mulia N; Ferreboeuf M; Carroll A; Vu C
AIDS Care; 2001 Oct; 13(5):561-77. PubMed ID: 11571004
[TBL] [Abstract][Full Text] [Related]
17. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic.
Rockwell R; Joseph H; Friedman SR
AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274
[TBL] [Abstract][Full Text] [Related]
18. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
19. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors.
Perngmark P; Vanichseni S; Celentano DD
Drug Alcohol Depend; 2008 Jan; 92(1-3):183-90. PubMed ID: 17870252
[TBL] [Abstract][Full Text] [Related]
20. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
Wozniak L; Prakash M; Taylor M; Wild TC
Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
